Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Yankees’ Teixeira Has No Structural Damage in Inflamed Wrist

July 31 (Bloomberg) -- New York Yankees All-Star first baseman Mark Teixeira underwent tests that showed no structural damage in his injured left wrist. He’ll be re-evaluated in three days, the team said.

Teixeira, who has 20 home runs and leads the Major League Baseball team with 71 runs batted in, was diagnosed with inflammation of the wrist and had a cortisone shot after today’s MRI exam, the Yankees said in a Twitter post.

Teixeira said he originally hurt his wrist swinging through a pitch in the Yankees’ July 29 loss to the Boston Red Sox. He tweaked the injury in last night’s loss to Baltimore when he dove for a ground ball and landed on his wrist. He wore a protective brace on his wrist after the game and said he’d probably miss several days before the injury heals.

The Yankees, who have lost three straight games, host the Orioles today and tomorrow. They’re off Aug. 2 before opening a three-game series at home on Aug. 3 against Seattle.

After Teixeira left last night’s game, Eric Chavez moved from third base to first to replace him. Nick Swisher, who hasn’t played in the field since July 20 because of a hip injury, can also play first base when healthy.

To contact the reporter on this story: Erik Matuszewski in New York at matuszewski@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.